Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Incidence and Risk Factors for Recurrence of NDM- and KPC-Producing Enterobacterales after Achieving Clearance: A Retrospective Study.

Infection & chemotherapy·2026
Same author

AI-powered real-time detection and classification of peritoneal nodules in colorectal cancer using multi-center laparoscopic data: A feasibility study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Juvenile idiopathic arthritis (JIA) in Korea: epidemiology and biologic treatments.

Journal of rheumatic diseases·2026
Same author

Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis.

Cell stem cell·2026
Same author

Evaluation of the association between MREPT-derived conductivity and IVIM-derived ISF-related metrics in the brains of patients with cognitive impairments.

Frontiers in aging neuroscience·2026
Same author

Effectiveness of chlorine treatment of hospital water systems in reducing the incidence of nosocomial legionellosis: a quasi-experimental study.

Infection control and hospital epidemiology·2026

相关实验视频

Updated: Jul 18, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.5K

使用修改双切N-甘氨酸的特定抗体结合:方法开发和潜在的可调节效应器功能.

Yen-Pang Hsu1, Omar Nourzaie2, Ariel E Tocher3

  • 1MRL, Merck & Co., Inc., 320 Bent St., Cambridge, Massachusetts 02141, United States.

Bioconjugate chemistry
|August 24, 2023
PubMed
概括

一种新的甘氨酸桥接结合策略,可以在没有复杂的抗体修饰的情况下创建特定位点的抗体-药物结合物 (ADC). 这种方法有效地准HER2表达的癌细胞,并允许糖基工程优化ADC特性.

更多相关视频

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

21.0K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

相关实验视频

Last Updated: Jul 18, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.5K
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

21.0K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

科学领域:

  • 生物结合化学 生物结合化学
  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.

背景情况:

  • 抗体-药物合物 (ADC) 由于其向特异性和强度,是重要的治疗药物.
  • 现有的ADC结合策略往往需要复杂的抗体工程.
  • 需要先进的结合方法,提供更好的生物相容性和受控的生物物理特性.

研究的目的:

  • 开发一个新的特定站点对ADCs的结合策略,使用一个分割的糖桥.
  • 证明这种策略在制造抗HER2ADC时的有效性.
  • 探索糖基工程调节ADC属性的潜力.

主要方法:

  • 采用了一种分割甘氨酸桥接的结合方法,绕过了对寡糖化合物合成或基因抗体工程的需求.
  • 使用这种策略,人类和小鼠的抗HER2 IgG与单甲基奥里斯塔丁E结合.
  • 评估了糖干桥的稳定性和由此产生的ADCs对HER2表达癌细胞的疗效.

主要成果:

  • 甘氨酸桥接结合策略使得特定部位的抗体修饰成为可能.
  • 开发的ADCs表现出极好的稳定性,并有效地消除了表达HER2的癌细胞.
  • 该策略被证明与潜在的甘氨酸工程的甘氨酸结构改造兼容.

结论:

  • 切割甘氨酸桥接联策略为创建特定站点的ADC提供了一种多功能和高效的方法.
  • 这种方法有助于开发具有可调制的药理动力学和免疫性特征的强效和稳定的ADC.
  • 该方法有望通过简化结合和糖基工程来推进基于ADC的癌症疗法.